Autoimmune liver disease: evaluating overlapping and cross-over presentations—a case-based discussion

The three classic autoimmune liver diseases are recognised based on identifying varying clinical, laboratory, histological and radiological features that collectively classify patients. In the absence of defined aetiological factors, it is recognised that disease spectrum is broad, and, in this context, it is not infrequent for disease boundaries to be blurred, leading to overlapping features that may be present at the time of diagnosis or may appear later in the course of disease. Given the absence of accepted diagnostic criteria for overlap/cross-over syndromes, alongside weak data for intervention, it is recommended that a multidisciplinary, patient-specific approach be used to establish individual treatment pathways.

[1]  P. Trivedi,et al.  Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists , 2015, Hepatology.

[2]  K. Lindor,et al.  Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. , 2015, Gastroenterology.

[3]  M. Taniai,et al.  Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  G. Alexander,et al.  Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. , 2013, Gastroenterology.

[5]  M. Manns,et al.  Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. , 2011, Journal of hepatology.

[6]  A. Czaja Autoantibodies as Prognostic Markers in Autoimmune Liver Disease , 2010, Digestive Diseases and Sciences.

[7]  Masahiro Ito,et al.  Anti‐gp210 and anti‐centromere antibodies are different risk factors for the progression of primary biliary cirrhosis , 2007, Hepatology.

[8]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[9]  O. Chazouilleres,et al.  Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy , 1998, Hepatology.

[10]  A. Czaja Frequency and nature of the variant syndromes of autoimmune liver disease , 1998, Hepatology.

[11]  P. Scheuer,et al.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. , 1994, Gut.

[12]  Lu Lun-ge,et al.  Overlap syndromes:the international autoimmune hepatitis group(IAIHG) position statement on a controversial issue , 2011 .

[13]  F. Lammert,et al.  EASL Clinical Practice Guidelines: management of cholestatic liver diseases. , 2009, Journal of hepatology.